FolioFact
Sign in

Viking Global Investors — BBIO

How Viking Global Investors's position in BridgeBio Pharma Inc. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarter Shares Value % of portfolio Change
Q1 2026 11,842,434 $879,419,149 2.46% TRIM
Q4 2025 14,393,934 $1,100,992,012 2.92% NEW